AI Aids Couple in Overcoming Male Infertility After 18 Years

After 18 years of trying to conceive, a couple is finally expecting their first child, thanks to advancements in artificial intelligence.

They had previously undergone multiple rounds of in vitro fertilization (IVF), traveling to various fertility clinics worldwide, seeking a breakthrough in their journey to parenthood.

During IVF, a woman’s egg is extracted and combined with sperm in a lab, aiming to create an embryo for implantation in her womb. However, this couple faced significant hurdles due to azoospermia, a rare condition where no measurable sperm is found in the male partner’s semen, contributing to male infertility. Typically, a semen sample contains hundreds of millions of sperm, but those with azoospermia often have counts so low that even extensive microscope examinations yield no sperm cells.

To protect their privacy, the couple chose to remain anonymous but sought out the Columbia University Fertility Center in hopes of a new approach.

They opted for a method known as STAR, which employs AI to locate and recover hidden sperm in men who previously believed they had none. The husband provided a semen sample to the medical team, which was met with cautious optimism.

“We kept our hopes to a minimum after so many disappointments,” the wife commented in an email.

The fertility center’s team analyzed the sample with the AI system, discovering three previously hidden sperm. These were then used to fertilize the wife’s eggs through IVF, marking the first successful pregnancy achieved by this method. The couple is expecting their baby in December.

“It took me two days to actually believe I was pregnant,” she shared. “Every morning, I still wake up questioning if this is true. I need to see the scans to fully accept it.”

AI’s role in fertility treatment is rising in the U.S., with medical facilities increasingly utilizing these technologies to assess egg quality and screen embryos during IVF. While the field continues to evolve, AI potentially represents a significant advance especially in addressing male infertility.

Dr. Zev Williams, director of the Columbia Fertility Center, and his team spent five years developing the STAR method focused on detecting and recovering sperm from those with azoospermia. They have been impressed with the system’s outcomes.

“A patient once provided a sample, and our skilled technicians searched for two days without success. Once we applied the AI-based STAR system, it identified 44 sperm in just one hour,” Dr. Williams recounted, recognizing the substantial difference this technology could make for patients.

When a semen sample is placed on a specialized chip and observed via a microscope, the STAR system interacts with it through high-speed cameras and advanced imaging technology, capturing over eight million images in under an hour. This allows the AI to identify sperm cells that technicians might easily overlook.

The AI can gently extract sperm cells without causing harm, offering a lifeline to those who might have previously felt hopeless about their fertility options.

“It’s almost like searching for a needle in a haystack, but completing the task efficiently and carefully,” Williams noted, emphasizing the precision of their approach.

A Shocking Revelation

It is estimated that the male partner contributes to up to 40% of infertility cases in the U.S., with around 10% of men experiencing azoospermia. “For many, this diagnosis can be shocking and heartbreaking,” Dr. Williams added. “Many men feel healthy and normal, but under close examination, their semen reveals no viable sperm.”

Traditional treatments for azoospermia often entail invasive surgeries to retrieve sperm directly from the testes, a painful procedure with risks of permanent damage.

Alternative options may include hormone medications, but these work only if hormonal imbalances exist. If all else fails, couples sometimes resort to donor sperm.

Williams believes that the STAR method could change the landscape of treatment. “Developing this technique required teamwork and dedication, aiming to assist couples who might otherwise miss out on parenthood,” he said.

Although the STAR method is only available at Columbia, there are plans to share this innovation with other fertility centers. The overall cost for utilizing this method is about $3,000.

“Infertility is an age-old challenge, and it’s fascinating to see modern technologies being applied to age-old issues,” he reflected.

Other researchers have also turned to AI for aid in addressing conditions like azoospermia. In Canada, a team developed an AI model to streamline the search for rare sperm within patient samples.

Dr. Sevann Helo from Mayo Clinic praised the technology, explaining that AI’s learning process helps it identify specific features of sperm, improving identification processes.

“It’s very exciting. In medicine, AI is truly altering the landscape,” she said.

Besides STAR, AI is already making waves in fertility treatments. For instance, algorithms analyze embryos to predict success rates, while other tools assess egg quality for future use.

Eyvazzadeh noted, “AI enhances our ability to make informed decisions and personalizes the patient experience.”

Despite the optimism surrounding AI, there are concerns regarding its rapid adoption in reproductive medicine, particularly in offering potentially misleading hopes to patients. Dr. Gianpiero Palermo highlighted that models still require consistent validation.

“While technologies may help expedite sperm retrieval, human intervention remains essential for successful fertilization,” he remarked.

He cautioned that while the STAR method might offer faster searches, limitations exist, and not every patient will find viable sperm.